NCT00889941

Brief Summary

The purpose of this study is to evaluate whether the size of the pupil has an effect on quality of vision in patients undergoing LASIK surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2004

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2004

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2005

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

February 12, 2009

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 29, 2009

Completed
Last Updated

April 29, 2009

Status Verified

April 1, 2009

Enrollment Period

1.5 years

First QC Date

February 12, 2009

Last Update Submit

April 28, 2009

Conditions

Study Arms (3)

small

ACTIVE COMPARATOR
Procedure: LASIK

medium

ACTIVE COMPARATOR
Procedure: LASIK

large

ACTIVE COMPARATOR
Procedure: LASIK

Interventions

LASIKPROCEDURE

laser-assisted in situ keratomileusis

Also known as: laser-assisted in situ keratomileusis
largemediumsmall

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • no more than 6.00 D of spherical myopia
  • no more than 3.00 D of refractive astigmatism
  • a stable refraction (less than 0.50D per year of sphere or cylinder)
  • a corneal diameter of less than 11.0 mm to allow for suction ring fixation
  • discontinuation of soft contact wear at least 7 days prior to preoperative evaluation
  • visual acuity correctable to at least 20/20
  • age older than 21 years
  • ability to participate in follow-up examinations for 12 months after LASIK surgery

You may not qualify if:

  • use of rigid gas permeable contact lens
  • severe dry eye symptoms
  • severe blepharitis
  • anterior segment abnormalities (i.e. cataracts, corneal scarring, or neovascularization within 1 mm of intended ablation zone)
  • recurrent corneal erosion
  • severe basement membrane disease
  • progressive or unstable myopia or keratoconus
  • unstable corneal mires on central keratometry
  • corneal thickness in which LASIK procedure would result in less than 250 microns of remaining posterior corneal thickness below the flap postoperatively
  • baseline standard manifest refraction of more than 0.75 D in sphere power
  • or a difference of greater than 0.50 D in cylinder power compared with baseline standard cycloplegic refraction
  • a baseline standard cycloplegic refraction differing more than 0.75 in sphere, 0.50 D in cylinder
  • have a different type of astigmatism (i.e. with-the-rule) when the cylinder is greater than 0.50D compared to baseline standard cycloplegic refraction
  • preoperative assessment of ocular topography and/or aberrations indicates that either eye is not suitable candidate for LASIK vision correction procedure (i.e. forme fruste keratoconus
  • corneal warpage, or pellucid marginal degeneration)
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Myopia

Interventions

Keratomileusis, Laser In Situ

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

Corneal Surgery, LaserLaser TherapyTherapeuticsAblation TechniquesSurgical Procedures, OperativeKeratectomyRefractive Surgical ProceduresOphthalmologic Surgical Procedures

Study Officials

  • Annie Chan

    Stanford University

    SUB INVESTIGATOR
  • Edward E. Manche

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 12, 2009

First Posted

April 29, 2009

Study Start

May 1, 2004

Primary Completion

November 1, 2005

Study Completion

November 1, 2005

Last Updated

April 29, 2009

Record last verified: 2009-04

Locations